Clinical trial
Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease
NCT05752968 is registered in ClinicalTrials.gov with Tungs' Taichung Metroharbour Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease
- Lead sponsor
- Tungs' Taichung Metroharbour Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 3, 2023
- Completion date
- December 31, 2023
- Enrollment
- 155 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.